SOX17 and aneurysm: CRISPR activation (CRISPRa)-mediated upregulation of SOX17 enhanced protective endothelial programs and reduced inflammatory and pro-degenerative signaling in IA models, establishing proof-of-concept for gene-editing–guided aneurysm wall stabilization (preclinical stage as of 2025) [99].